Trofile assay

WikiDoc Resources for Trofile assay
Articles
Most recent articles on Trofile assay Most cited articles on Trofile assay Review articles on Trofile assay Articles on Trofile assay in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Trofile assay Images of Trofile assay Photos of Trofile assay Podcasts & MP3s on Trofile assay Videos on Trofile assay
Evidence Based Medicine
Cochrane Collaboration on Trofile assay Bandolier on Trofile assay TRIP on Trofile assay
Clinical Trials
Ongoing Trials on Trofile assay at Clinical Trials.gov Trial results on Trofile assay Clinical Trials on Trofile assay at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Trofile assay NICE Guidance on Trofile assay NHS PRODIGY Guidance FDA on Trofile assay CDC on Trofile assay
Books
Books on Trofile assay
News
Trofile assay in the news Be alerted to news on Trofile assay News trends on Trofile assay
Commentary
Blogs on Trofile assay
Definitions
Definitions of Trofile assay
Patient Resources / Community
Patient resources on Trofile assay Discussion groups on Trofile assay Patient Handouts on Trofile assay Directions to Hospitals Treating Trofile assay Risk calculators and risk factors for Trofile assay
Healthcare Provider Resources
Symptoms of Trofile assay Causes & Risk Factors for Trofile assay Diagnostic studies for Trofile assay Treatment of Trofile assay
Continuing Medical Education (CME)
CME Programs on Trofile assay
International
Trofile assay en Espanol Trofile assay en Francais
Business
Trofile assay in the Marketplace Patents on Trofile assay
Experimental / Informatics
List of terms related to Trofile assay

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

The Trofile (TM) assay is a blood test that identifies the tropism of a patient's HIV.

A molecular assay, Trofile was developed by Monogram Biosciences for use in HIV treatment. The assay's purpose is to identify the tropism of an individual patient's HIV strain – R5, X4, or a combination of these known as dual/mixed (D/M). The results show whether the patient is infected with virus that enters cells using the R5 co-receptor, the X4 co-receptor, or both (dual/mixed).

Patients with strains of HIV that prefer the R5 receptor tend to remain healthy longer than those with the strains that prefer X4. However, over the course of the disease, a patient's viral population may undergo a "tropism switch" from R5 to X4.

References

• Development and characterization of a novel single-cycle recombinant virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrob Agents Chemother. 2007;51(2):566-575. (Whitcomb JM, Huang W, Fransen S, et al.)

External links

• TrofileAssay.com Monogram Biosciences' Trofile assay website
• Four Studies Affirm Significance Of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay from Medical News Today, August 14, 2006
• Monogram Provides Update On Trofile(TM) Assay from Medical News Today, March 2, 2007
• Scientific Data Highlights Pivotal Role Of Monogram's Molecular Diagnostics In Development And Use Of New HIV Treatments from Medical News Today, March 7, 2007